Pharmaceutical Intellectual Property Rights and the Single Market: A Survey of the Jurisprudence of the European Court of Justice - Brossura
Sinossi
Thesis (M.A.) from the year 2006 in the subject Law - European and International Law, Intellectual Properties, grade: 13,53 (gut) , Justus-Liebig-University Giessen, course: Magister Juris Internationalis, language: English, abstract: With an aging demographic all over the European Union, the European pharmaceutical sector is set to grow in the coming decades. Al-ready today the pharmaceutical industry is a key employer in Europe. At the same time, the pharmaceutical industry is marked by a very ex-pensive research and development phase, which makes strong intellectual property rights crucial to ensure that research for new pharmaceuticals remains commercially interesting. But not only direct threats to intellectual property rights, such as the production of generic phar-maceuticals or the sale of counterfeit pharmaceuticals, pose a threat to those pharmaceutical companies which heavily invest in research for the development of new products: different prices for identical pharmaceuticals in different member states of the European Community make it economically interesting to buy pharmaceuticals in one member state and sell them abroad. It might even be cheaper to sell reimported pharmaceuticals in the country of origin. This possibility opens a whole new market for reimporters which cuts directly into the profit of the producers. In this thesis we will look at different issues surrounding intellectual property rights in the European pharmaceutical sector by investigating the jurisprudence of the European Court of Justice and the Court of First Instance.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
L'autore
RA Dr. Stefan Kirchner, MJI, is an international legal consultant, admitted to the bar in Germany (www.marine-consulting-eu). He has worked at the Law of the Sea Division of the German Foreign Ministry in Berlin and at the German Federal Maritime and Hydrographic Agency. He has been Assistant Professor for the Law of the Sea in Kaunas and Associate Professor for Fundamental and Human Rights in Rovaniemi. After serving as Co-Chair of the Rights of Indigenous Peoples Interest Group of the American Society of International Law he now holds that position in ASIL's Law of the Sea Interest Group.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Risultati della ricerca per Pharmaceutical Intellectual Property Rights and the...
Foto dell'editore
Pharmaceutical Intellectual Property Rights and the Single Market: A Survey of the Jurisprudence of the European Court of Justice
Da: California Books, Miami, FL, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. Codice articolo I-9783640456505
Compra nuovo
EUR 61,20
Spedizione gratuita
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
Pharmaceutical Intellectual Property Rights and the Single Market
Print on DemandDa: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Thesis (M.A.) from the year 2006 in the subject Law - European and International Law, Intellectual Properties, grade: 13,53 (gut) , Justus-Liebig-University Giessen, course: Magister Juris Internationalis, language: English, abstract: With an aging demographic all over the European Union, the European pharmaceutical sector is set to grow in the coming decades. Al-ready today the pharmaceutical industry is a key employer in Europe. At the same time, the pharmaceutical industry is marked by a very ex-pensive research and development phase, which makes strong intellectual property rights crucial to ensure that research for new pharmaceuticals remains commercially interesting. But not only direct threats to intellectual property rights, such as the production of generic phar-maceuticals or the sale of counterfeit pharmaceuticals, pose a threat to those pharmaceutical companies which heavily invest in research for the development of new products: different prices for identical pharmaceuticals in different member states of the European Community make it economically interesting to buy pharmaceuticals in one member state and sell them abroad. It might even be cheaper to sell reimported pharmaceuticals in the country of origin. This possibility opens a whole new market for reimporters which cuts directly into the profit of the producers. In this thesis we will look at different issues surrounding intellectual property rights in the European pharmaceutical sector by investigating the jurisprudence of the European Court of Justice and the Court of First Instance. 88 pp. Englisch. Codice articolo 9783640456505
Compra nuovo
EUR 47,95
Spedizione EUR 23,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 2 disponibili
Foto dell'editore
Pharmaceutical Intellectual Property Rights and the Single Market
Print on DemandDa: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
Condizione: New. Print on Demand pp. 88. Codice articolo 388978391
Compra nuovo
EUR 77,98
Spedizione EUR 7,51
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: 4 disponibili
Immagini fornite dal venditore
Pharmaceutical Intellectual Property Rights and the Single Market
Editore:
GRIN Verlag, GRIN Verlag Okt 2009, 2009
ISBN 10: 3640456505
ISBN 13: 9783640456505
Nuovo
Taschenbuch
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Thesis (M.A.) from the year 2006 in the subject Law - European and International Law, Intellectual Properties, grade: 13,53 (gut) , Justus-Liebig-University Giessen, course: Magister Juris Internationalis, language: English, abstract: With an aging demographic all over the European Union, the European pharmaceutical sector is set to grow in the coming decades. Al-ready today the pharmaceutical industry is a key employer in Europe. At the same time, the pharmaceutical industry is marked by a very ex-pensive research and development phase, which makes strong intellectual property rights crucial to ensure that research for new pharmaceuticals remains commercially interesting. But not only direct threats to intellectual property rights, such as the production of generic phar-maceuticals or the sale of counterfeit pharmaceuticals, pose a threat to those pharmaceutical companies which heavily invest in research for the development of new products: different prices for identical pharmaceuticals in different member states of the European Community make it economically interesting to buy pharmaceuticals in one member state and sell them abroad. It might even be cheaper to sell reimported pharmaceuticals in the country of origin. This possibility opens a whole new market for reimporters which cuts directly into the profit of the producers. In this thesis we will look at different issues surrounding intellectual property rights in the European pharmaceutical sector by investigating the jurisprudence of the European Court of Justice and the Court of First Instance.Books on Demand GmbH, Überseering 33, 22297 Hamburg 88 pp. Englisch. Codice articolo 9783640456505
Compra nuovo
EUR 47,95
Spedizione EUR 60,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili
Immagini fornite dal venditore
Pharmaceutical Intellectual Property Rights and the Single Market : A Survey of the Jurisprudence of the European Court of Justice
Editore:
GRIN Verlag, GRIN Verlag, 2009
ISBN 10: 3640456505
ISBN 13: 9783640456505
Nuovo
Taschenbuch
Da: AHA-BUCH GmbH, Einbeck, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Thesis (M.A.) from the year 2006 in the subject Law - European and International Law, Intellectual Properties, grade: 13,53 (gut) , Justus-Liebig-University Giessen, course: Magister Juris Internationalis, language: English, abstract: With an aging demographic all over the European Union, the European pharmaceutical sector is set to grow in the coming decades. Al-ready today the pharmaceutical industry is a key employer in Europe. At the same time, the pharmaceutical industry is marked by a very ex-pensive research and development phase, which makes strong intellectual property rights crucial to ensure that research for new pharmaceuticals remains commercially interesting. But not only direct threats to intellectual property rights, such as the production of generic phar-maceuticals or the sale of counterfeit pharmaceuticals, pose a threat to those pharmaceutical companies which heavily invest in research for the development of new products: different prices for identical pharmaceuticals in different member states of the European Community make it economically interesting to buy pharmaceuticals in one member state and sell them abroad. It might even be cheaper to sell reimported pharmaceuticals in the country of origin. This possibility opens a whole new market for reimporters which cuts directly into the profit of the producers. In this thesis we will look at different issues surrounding intellectual property rights in the European pharmaceutical sector by investigating the jurisprudence of the European Court of Justice and the Court of First Instance. Codice articolo 9783640456505
Compra nuovo
EUR 47,95
Spedizione EUR 60,71
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili
Immagini fornite dal venditore
Pharmaceutical Intellectual Property Rights and the Single Market | A Survey of the Jurisprudence of the European Court of Justice
Da: preigu, Osnabrück, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. Pharmaceutical Intellectual Property Rights and the Single Market | A Survey of the Jurisprudence of the European Court of Justice | Stefan Kirchner | Taschenbuch | 88 S. | Englisch | 2009 | GRIN Verlag | EAN 9783640456505 | Verantwortliche Person für die EU: GRIN Publishing GmbH, Waltherstr. 23, 80337 München, info[at]grin[dot]com | Anbieter: preigu. Codice articolo 101458435
Compra nuovo
EUR 47,95
Spedizione EUR 70,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 5 disponibili